| Filed On | Filing |
|---|---|
| 01 Oct 2026 |
Form 3: Manning Meredith, Director
No securities owned |
| 29 Sep 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events
Resubmission of NDA includes Chemistry, Manufacturing, and Controls (CMC) data from a new drug product manufacturing vendor |
| 28 Sep 2026 |
8-K: Other Events
On September 3, 2026, a securities class action lawsuit was filed in United States District Court for the Northern District of California against Unicycive Therapeutics, Inc. (the “Company”) and certain of its officers. This action alleg... |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Aug 2026 | QUARTERLY REPORT |
| 30 Jul 2026 | SCHEDULE 13G |
| 28 Jul 2026 |
Form 4/A: Kenkare-Mitra Sara, Director
Granted 47,941 Restricted Stock Units |
| 28 Jul 2026 |
Form 4/A: Laumas Sandeep, Director
Granted 47,941 Restricted Stock Units |
| 08 Jul 2026 | SCHEDULE 13G/A |
| 02 Jul 2026 | 8-K: Other Events |
| 01 Jul 2026 | 144 |
| 22 Jun 2026 | CURRENT REPORT |
| 22 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 15 Jun 2026 | EFFECT |
| 15 Jun 2026 |
Form 4/A: Gupta Shalabh K., Director
Granted 762,200 Restricted Stock Units |
| 15 Jun 2026 |
Form 4/A: Kenkare-Mitra Sara, Director
Granted 126,300 Restricted Stock Units |
| 15 Jun 2026 |
Form 4/A: Laumas Sandeep, Director
Granted 126,300 Restricted Stock Units |
| 15 Jun 2026 |
Form 4/A: Gupta Pramod, EVP, Pharmaceuticals and BD
Granted 169,500 Restricted Stock Unit |
Loading...
